NCT02454361View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics of KBP-7072

PHASE1CompletedINTERVENTIONAL

Enrollment

46

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

December 31, 2015

Conditions

Healthy

Interventions

DRUG

KBP-7072

KBP-7072

DRUG

Placebo

Placebo

Trial Locations (1)

08540

KBP, Princeton

Sponsors

Lead Sponsor

KBP Biosciences

All Listed Sponsors

lead

KBP Biosciences

INDUSTRY

NCT02454361 - Safety, Tolerability and Pharmacokinetics of KBP-7072 | Biotech Hunter | Biotech Hunter